Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity
Introduction This paper summarizes the safety and immunogenicity data of Influvac Tetra across all age groups starting from 6 months of age, obtained during its clinical development program.Areas covered The article covers the clinical development program of Influvac Tetra based on five registration...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Expert Review of Vaccines |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2023.2293241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|